Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Sep 15, 2006 (Vol. 26, No. 16)

Digital Atlas of Actinomycetes

URL:www.nih.go.jp/saj/DigitalAtlas
  • Images
  • Lacks enough technical info
Were you aware that actinomycetes are the source of about two-thirds of known bioactive compounds? How about that they are a valuable source of vitamins and enzymes? Okay, let’s start simply. Actinomycetes are a group of gram-positive bacteria that mainly inhabit soil and perform important roles in recycling compounds and degrading organic material. They are unusual prokaryotes in exhibiting filamentous growth and forming spores. They are also important sources of antibiotics. At the Digital Atlas of Actinomycetes site, visitors learn of these interesting facts and can access information and pictures of the numerous species of this class of organisms. Though technical data is a bit sparse, the pix are good, as well as the general descriptions.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »